Usages of Nanomedicines in The Delivery of Antimicrobial Peptide
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Peptides".
Deadline for manuscript submissions: closed (30 December 2020) | Viewed by 212
Special Issue Editor
Interests: antimicrobial nanoformulation; antimicrobial peptides; antimicrobial resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Due to rapidly increasing resistance development against conventional antibiotics, new molecules and therapies are urgently needed to effectively kill a wide range of Gram-positive and negative bacteria along with multi-drug resistance bacteria. In the last few years, antimicrobial peptides are considered to be alternative to antibiotics because antimicrobial peptides play an important role to overcome bacterial resistance. Antimicrobial peptides are small peptide-based molecules of 5 to 40 amino acids in length, with potent and broad-spectrum antimicrobial properties. Some of the antimicrobial peptides have immune-modulation, angiogenesis, skin regeneration, and anticancer properties. Moreover, they are part of the innate immune system, and therefore have a minimal risk of bacterial resistance development.
Besides, there is of great interest in the development of potent and safe antimicrobial peptides-based therapeutics due to the degradation of antimicrobial peptides by proteases present in the human body. The development of nanomedicine provides a new way to optimize drug delivery systems. Could we make a breakthrough both way to fight bacteria resistance?
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Antimicrobial peptide conjugated NPs
- antimicrobial peptide synthesized NPs
- wound healing
- antimicrobial peptide conjugated NPs in infection control
- biomedical applications of antimicrobial peptide conjugated NPs
- antimicrobial peptide-NPs coated surfaces and fiber
